No Data
No Data
BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn in ALS
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Brainstorm Cell Therapeutics (BCLI)
12 Health Care Stocks Moving In Friday's After-Market Session
BrainStorm Cell Therapeutics Reports 2024 Financial Results
Earnings Call Summary | Brainstorm Cell Therapeutics(BCLI.US) Q4 2024 Earnings Conference
Brainstorm Cell Therapeutics | 10-K: FY2024 Annual Report